Antifungal prophylaxis in lung transplantation-a world-wide survey

American Journal of Transplantation

Volumn 11, Issue 2, 2011, Pages 361-366

  Neoh, C F ^a   Snell, G I ^b   Kotsimbos, T ^b   Levvey, B ^b   Morrissey, C O ^b   Slavin, M A ^b,c   Stewart, K ^a   Kong, D C M ^a  

^a MONASH UNIVERSITY   (Australia)

^b The Alfred   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Antifungal prophylaxis; lung transplant; survey; voriconazole

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; VORICONAZOLE;

ADMINISTRATIVE PERSONNEL; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; CANDIDA; CANDIDIASIS; CLINICAL PRACTICE; DRUG MONITORING; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; HEALTH SURVEY; HUMAN; INFECTION PREVENTION; LUNG TRANSPLANTATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSEUDALLESCHERIASIS; SCEDOSPORIUM; UNSPECIFIED SIDE EFFECT;

EID: 79551496183     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03375.x     Document Type: Article

References (20)

1. Sole A, Salavert M,. Fungal infections after lung transplantation. Transplant Rev (Orlando) 2008; 22: 89-104.
2. Singh N, Husain S,. Invasive aspergillosis in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl. 4): S180-S191.
3. Husain S, Zaldonis D, Kusne S, Kwak EJ, Paterson DL, McCurry KR,. Variation in antifungal prophylaxis strategies in lung transplantation. Transpl Infect Dis 2006; 8: 213-218.
4. Levine SM,. A survey of clinical practice of lung transplantation in North America. Chest 2004; 125: 1224-1238.
5. Dummer JS, Lazariashvilli N, Barnes J, Ninan M, Milstone AP,. A survey of anti-fungal management in lung transplantation. J Heart Lung Transplant 2004; 23: 1376-1381.
6. Husain S, Paterson DL, Studer S, et al,. Voriconazole prophylaxis in lung transplant recipients. Am J Transplant 2006; 6: 3008-3016.
7. Fungal infections. Am J Transplant 2004; 4 (Suppl. 10): 110-134.
8. Cadena J, Levine DJ, Angel LF, et al,. Antifungal prophylaxis with voriconazole or itraconazole in lung transplant recipients: Hepatotoxicity and effectiveness. Am J Transplant 2009; 9: 2085-2091.
9. Lehneman JB, Smallwood GA, Lesniak LA, Lawrence EC,. Review of patient outcomes of aspergillus prophylaxis with voriconazole after lung transplantation (abstract). J Heart Lung Transplant 2005; 24 (Suppl. 1): S169.
10. Miller DD, Cowen EW, Nguyen JC, McCalmont TH, Fox LP,. Melanoma associated with long-term voriconazole therapy: A new manifestation of chronic photosensitivity. Arch Dermatol 2010; 146: 300-304.
11. Chambers DC, Nguyen LK, Heath CH, et al,. Use of posaconazole, a new broad spectrum triazole antifungal, in lung transplantation (abstract). J Heart Lung Transplant 2008; 27 (Suppl. 1): S142.
12. Fortun J, Martin-Davila P, Montejo M, et al,. Prophylaxis with caspofungin for invasive fungal infections in high-risk liver transplant recipients. Transplantation 2009; 87: 424-435.
13. Groetzner J, Kaczmarek I, Wittwer T, et al,. Caspofungin as first line therapy for the treatment of invasive aspergillosis after thoracic organ transplantation. J Heart Lung Transplant 2008; 27: 1-6.
14. Crandon JL, Banevicius MA, Fang AF, et al,. Bronchopulmonary disposition of intravenous voriconazole and anidulafungin given in combination to healthy adults. Antimicrob Agents Chemother 2009; 53: 5102-5107.
15. Singh N, Wagener MM, Cacciarelli TV, Levitsky J,. Antifungal management practices in liver transplant recipients. Am J Transplant 2008; 8: 426-431.
16. Vehreschild JJ, Ruping MJ, Steinbach A, Cornely OA,. Diagnosis and treatment of fungal infections in allogeneic stem cell and solid organ transplant recipients. Expert Opin Pharmacother 2010; 11: 95-113.
17. Borro JM, Sole A, de la Torre M, Pastor A, et al,. Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation. Transplant Proc 2008; 40: 3090-3093.
18. Monforte V, Ussetti P, Gavalda J, et al,. Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation. J Heart Lung Transplant 2010; 29: 523-530.
19. Berge M, Guillemain R, Boussaud V, et al,. Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients. Transpl Infect Dis 2009; 11: 211-219.
20. Andes D, Pascual A, Marchetti O,. Antifungal therapeutic drug monitoring: Established and emerging indications. Antimicrob Agents Chemother 2009; 53: 24-34.